Dataset Information


Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review.



The rapid spread of novel coronavirus called SARS-CoV-2 or nCoV has caused countries all over the world to impose lockdowns and undertake stringent preventive measures. This new positive-sense single-stranded RNA strain of coronavirus spreads through droplets of saliva and nasal discharge.


US FDA has authorized the emergency use of Remdesivir looking at the increasing number of cases of COVID-19, however there is still no drug approved to treat COVID-19. An alternative way of treatment could be the use of naturally derived molecules with known antiviral properties.


We reviewed the antiviral activities of two polyphenols derived from tea, epigallocatechin-3-gallate (EGCG) from green tea and theaflavins from black tea. Both green tea and black tea polyphenols have been reported to exhibit antiviral activities against various viruses, especially positive-sense single-stranded RNA viruses.


Recent studies have revealed the possible binding sites present on SARS-CoV-2 and studied their interactions with tea polyphenols. EGCG and theaflavins, especially theaflavin-3,3'-digallate (TF3) have shown a significant interaction with the receptors under consideration in this review. Some docking studies further emphasize on the activity of these polyphenols against COVID-19.


This review summarizes the available reports and evidences which support the use of tea polyphenols as potential candidates in prophylaxis and treatment of COVID-19.


PROVIDER: S-EPMC7367004 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

2021-01-01 | S-EPMC7682485 | BioStudies
2020-01-01 | S-EPMC7499281 | BioStudies
2012-01-01 | S-EPMC3310370 | BioStudies
2016-01-01 | S-EPMC5047449 | BioStudies
2020-01-01 | S-EPMC7441777 | BioStudies
2015-01-01 | S-EPMC5669444 | BioStudies
2012-01-01 | S-EPMC3303150 | BioStudies
2020-01-01 | S-EPMC7332865 | BioStudies
2018-01-01 | S-EPMC6261387 | BioStudies
2020-01-01 | S-EPMC7404268 | BioStudies